HENRY M. JACKSON FDN FOR THE ADV MIL/MED
Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents
Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents is a funding opportunity from HENRY M. JACKSON FDN FOR THE ADV MIL/MED, up to 721888, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Nerve agents are lethal chemical weapons that have been used in war and terrorist attacks, with devastating consequences. The risk for mass exposure to nerve agents is presently very high. One of the clinical manifestations of acute exposure to nerve agents is seizure activity progressing to status epilepticus (SE),…